BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Misawa K, Mochizuki D, Imai A, Mima M, Misawa Y, Mineta H. Analysis of Site-Specific Methylation of Tumor-Related Genes in Head and Neck Cancer: Potential Utility as Biomarkers for Prognosis. Cancers (Basel) 2018;10:E27. [PMID: 29361757 DOI: 10.3390/cancers10010027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Szylberg M, Sokal P, Śledzińska P, Bebyn M, Krajewski S, Szylberg Ł, Szylberg A, Szylberg T, Krystkiewicz K, Birski M, Harat M, Włodarski R, Furtak J. MGMT Promoter Methylation as a Prognostic Factor in Primary Glioblastoma: A Single-Institution Observational Study. Biomedicines 2022;10:2030. [DOI: 10.3390/biomedicines10082030] [Reference Citation Analysis]
2 Ma C, Xiong J, Su H, Li H. The underlying molecular mechanism and drugs for treatment in adrenal cortical carcinoma. Int J Med Sci 2021;18:3026-38. [PMID: 34220331 DOI: 10.7150/ijms.60261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Liang Y, Lv Z, Huang G, Qin J, Li H, Nong F, Wen B. Prognostic significance of abnormal matrix collagen remodeling in colorectal cancer based on histologic and bioinformatics analysis. Oncol Rep 2020;44:1671-85. [PMID: 32945508 DOI: 10.3892/or.2020.7729] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
4 Chen Y, Chen W, Dai X, Zhang C, Zhang Q, Lu J. Identification of the collagen family as prognostic biomarkers and immune-associated targets in gastric cancer. Int Immunopharmacol 2020;87:106798. [PMID: 32693357 DOI: 10.1016/j.intimp.2020.106798] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
5 Agarwal P, Agrawal RR, Jones EA, Devaiah AK. Social Determinants of Health and Oral Cavity Cancer Treatment and Survival: A Competing Risk Analysis. Laryngoscope 2020;130:2160-5. [PMID: 31654440 DOI: 10.1002/lary.28321] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
6 Guo Y, Yang J, Huang Q, Hsueh C, Zheng J, Wu C, Chen H, Zhou L. Circular RNAs and their roles in head and neck cancers. Mol Cancer 2019;18:44. [PMID: 30898135 DOI: 10.1186/s12943-019-1003-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
7 Misawa K, Kanazawa T, Mochizuki D, Imai A, Mima M, Yamada S, Morita K, Misawa Y, Shinmura K, Mineta H. Genes Located on 18q23 Are Epigenetic Markers and Have Prognostic Significance for Patients with Head and Neck Cancer. Cancers (Basel) 2019;11:E401. [PMID: 30901947 DOI: 10.3390/cancers11030401] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
8 Mochizuki D, Misawa Y, Kawasaki H, Imai A, Endo S, Mima M, Yamada S, Nakagawa T, Kanazawa T, Misawa K. Aberrant Epigenetic Regulation in Head and Neck Cancer Due to Distinct EZH2 Overexpression and DNA Hypermethylation. Int J Mol Sci 2018;19:E3707. [PMID: 30469511 DOI: 10.3390/ijms19123707] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
9 Misawa K, Imai A, Mochizuki D, Mima M, Endo S, Misawa Y, Kanazawa T, Mineta H. Association of TET3 epigenetic inactivation with head and neck cancer. Oncotarget 2018;9:24480-93. [PMID: 29849955 DOI: 10.18632/oncotarget.25333] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]